Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.

Blood - 1 Jan 2001

Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, Krukemeier S, Eilers M, Strauss G, Welte K

Abstract excerpt

Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare disease presenting with isolated thrombocytopenia in infancy and developing into a pancytopenia in later childhood. Thrombopoietin (TPO) is the main regulator of thrombocytopoiesis and has also been demonstrated to be an important factor in early hematopoiesis. We analyzed 9 patients with CAMT for defects in TPO production and reactivity. We found high...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Diphosphate
Share to Colony-Forming Units Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Megakaryocytes

Share to Pancytopenia

Share to Platelet Activation

Share to Receptors, Cytokine

Share to Receptors, Thrombopoietin

Share to Thrombopoietin

Source

Identifiers

PMID: 11133753
DOI: 10.1182/blood.v97.1.139

Genes

TPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.PMID 11133753Read ↗

Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopeniaSemantic proximity Read ↗

[Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].Semantic proximity Read ↗

Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.Semantic proximity Read ↗

Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.Semantic proximity Read ↗

[From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].Semantic proximity Read ↗

Congenital amegakaryocytic thrombocytopenia.Semantic proximity Read ↗

MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.Semantic proximity Read ↗

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients.Semantic proximity Read ↗

Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment.Semantic proximity Read ↗

Congenital amegakaryocytic thrombocytopenic purpura (CAMT).Semantic proximity Read ↗

Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations.Semantic proximity Read ↗

Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.